Lee, Jae Cheol, Jen-Yu Hung, Young-Chul Kim, Gee-Chen Chang, Seung Yoo, Sheng-Hsiung Yang, Keith Davis, Saurabh Nagar, Aliki Taylor, Sung Lee, and Jin-Yuan Shih. “Real-World Treatment Patterns in Patients With EGFR Mutation-Positive NSCLC Receiving a First-Line, First- or Second-Generation EGFR Tyrosine Kinase Inhibitor in South Korea and Taiwan”. Asian Pacific Journal of Cancer Biology 6, no. 2 (May 20, 2021): 123-132. Accessed October 16, 2021. http://waocp.com/journal/index.php/apjcb/article/view/663.